About
Biogen appears at No. 847 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Cambridge, Massachusetts, United States and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $9.6B in sales, $1.4B in profit, $29.5B in assets and a market value of $28.5B.